Correlation between serum pro‐inflammatory cytokine levels and the prognosis of the patients with acute liver failure
- 20 July 2023
- journal article
- research article
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 38 (9) , 1637-1646
Abstract
Background and Aim: The prognosis of acute liver failure (ALF) remains poor, and liver transplantation is an alternative treatment option. Assessing the prognosis of ALF is important in determining treatment strategies. Here, we investigated clinical factors including serum pro‐inflammatory cytokine levels that are associated with the prognosis of ALF.Methods: Sixty‐six patients who developed ALF were enrolled in this study. Serum concentrations of 12 pro‐inflammatory cytokines were measured on admission. The prognosis and factors associated with survival and development of hepatic coma were analyzed.Results: Of 66 patients, 4 patients underwent liver transplantation, and 49 patients were rescued without liver transplantation, while the remaining 13 patients died. Serum concentrations of interleukin (IL)‐1β, IL‐4, IL‐6, IL‐8, IL‐13, TNF, IFN ‐γ, IP‐10, and G‐CSF were significantly elevated in ALF patients. IL‐4 and IL‐8 levels were higher in patients who underwent liver transplantation or died than in rescued patients. Multivariable analysis identified age ≥ 55 years and IL‐4 ≥ 1.2 pg/mL on admission as independent factors for mortality. Serum IL‐8 levels were higher in patients with hepatic coma, and prothrombin‐international normalized ratio ≥ 3.5 and IL‐8 ≥ 77.2 pg/mL on admission were associated with development of hepatic coma after admission.Conclusion: Serum levels of several pro‐inflammatory cytokines were elevated in ALF patients. IL‐4 and IL‐8 were correlated with survival and development of hepatic coma after admission, respectively. Measurement of serum pro‐inflammatory cytokines seems to be useful for the management of ALF.Keywords
This publication has 40 references indexed in Scilit:
- Acute liver failure in Japan: definition, classification, and prediction of the outcomeJournal of Gastroenterology, 2012
- Safety and Efficacy of Tocilizumab for the Treatment of Rheumatoid ArthritisClinical Medicine Insights: Arthritis and Musculoskeletal Disorders, 2012
- Management of severe acute to fulminant hepatitis B: to treat or not to treat or when to treat?Liver International, 2011
- Tumour necrosis factor-α and soluble Fas ligand as biomarkers in non-acetaminophen-induced acute liver failureBiomarkers, 2009
- Acute liver failureHepatology, 2007
- MELD is Superior to King's College and Clichy's Criteria to Assess Prognosis in Fulminant Hepatic Failure†Liver Transplantation, 2007
- MELD score as a predictor of liver failure and death in patients with acetaminophen-induced liver injuryHepatology, 2007
- IL-6: a regulator of the transition from neutrophil to monocyte recruitment during inflammationTrends in Immunology, 2003
- Maintenance infliximab for Crohn's disease: the ACCENT I randomised trialThe Lancet, 2002
- The systemic inflammatory response syndrome in acute liver failureHepatology, 2000